Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely levobupivacaine (as levobupivacaine hydrochloride) 25 milligram/10 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Levobupivacaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levobupivacaine (as levobupivacaine hydrochloride) 50 milligram/10 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Levobupivacaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levobupivacaine (as levobupivacaine hydrochloride) 75 milligram/10 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Levobupivacaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levobupivacaine (as levobupivacaine hydrochloride) 62.5 milligram/100 milliliter conventional release solution for injection bag |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Levobupivacaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levobupivacaine (as levobupivacaine hydrochloride) 125 milligram/200 milliliter conventional release solution for injection bag |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Levobupivacaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levobupivacaine (as levobupivacaine hydrochloride) 125 milligram/100 milliliter conventional release solution for injection bag |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Levobupivacaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levobupivacaine (as levobupivacaine hydrochloride) 250 milligram/200 milliliter conventional release solution for infusion bag |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Levobupivacaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levobupivacaine (as levobupivacaine hydrochloride) 1.25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Levobupivacaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levobupivacaine (as levobupivacaine hydrochloride) 7.5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Levobupivacaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Levobupivacaine (as levobupivacaine hydrochloride) 625 microgram/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Levobupivacaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Levobupivacaine (as levobupivacaine hydrochloride) 1.25 mg/mL solution for infusion |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Levobupivacaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levobupivacaine (as levobupivacaine hydrochloride) 2.5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Levobupivacaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Levobupivacaine (as levobupivacaine hydrochloride) 5 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Levobupivacaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levobupivacaine (as levobupivacaine hydrochloride) 1.25 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Levobupivacaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Levobupivacaine (as levobupivacaine hydrochloride) 7.5 mg/mL solution for infusion and/or injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Levobupivacaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Levobupivacaine (as levobupivacaine hydrochloride) 7.5 mg/mL solution for infusion |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Levobupivacaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Levobupivacaine (as levobupivacaine hydrochloride) 2.5 mg/mL solution for infusion and/or injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Levobupivacaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Levobupivacaine (as levobupivacaine hydrochloride) 2.5 mg/mL solution for infusion |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Levobupivacaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Levobupivacaine (as levobupivacaine hydrochloride) 5 mg/mL solution for infusion |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Levobupivacaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Levobupivacaine (as levobupivacaine hydrochloride) 5 mg/mL solution for infusion and/or injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Levobupivacaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |